Steve Bai
Yale University(US)
Publications by Year
Research Areas
Blood Coagulation and Thrombosis Mechanisms, Atrial Fibrillation Management and Outcomes, Political Conflict and Governance, Meta-analysis and systematic reviews, Computational Drug Discovery Methods
Most-Cited Works
- → 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials(2018)313 cited
- → Discovery of 1-(3‘-Aminobenzisoxazol-5‘-yl)-3-trifluoromethyl-N-[2-fluoro-4- [(2‘-dimethylaminomethyl)imidazol-1-yl]phenyl]-1H-pyrazole-5-carboxyamide Hydrochloride (Razaxaban), a Highly Potent, Selective, and Orally Bioavailable Factor Xa Inhibitor(2004)188 cited
- → Aminobenzisoxazoles with biaryl P4 moieties as potent, selective, and orally bioavailable factor Xa inhibitors(2006)20 cited
- → Regional Treatment Effects in Studies of Cardiorenal Drugs(2012)9 cited
- → Loyalty Signaling, Bureaucratic Compliance, and Variation in State Repression in Authoritarian Regimes(2024)6 cited
- → Authoritarian cue effect of state repression(2024)3 cited
- → Sex-Related Differences in QTc Effects Potential of Drugs(2011)2 cited
- → The Zeal of the Outgroup: Loyalty Signaling and Bureaucratic Compliance in China’s Anti-Rightist Campaign (1957–1958)(2021)
- → DO CALCIUM CHANNEL BLOCKERS ALTER VASCULAR RESPONSIVENESS?(1987)
- → Aminobenzisoxazoles with Biaryl P4 Moieties as Potent, Selective, and Orally Bioavailable Factor Xa Inhibitors.(2006)